FDA approves Lilly pill for common advanced breast cancer
U.S. regulators have approved a new medicine for treating a common type of breast cancer that has spread to other parts of the body.
Eli Lilly's Verzenio (verr-ZEHN'ee-oh) was approved Thursday by the Food and Drug Administration for patients with what's called HR-positive, HER2-negative breast cancer that has worsened after hormone therapy.
According to the FDA, about 72 percent of patients with breast cancer have this type.
The daily pill is to be used either alone, after hormone therapy and chemotherapy have stopped working, or in combination with a hormone therapy called fulvestrant.... read more
- 04:30 Koch network success in Trump era draws Democratic pushback
- 21:38 Diamondbacks down Padres, roll to another series victory
- 18:43 Reports: Cardinals safety Budda Baker's brother killed in Seattle...
- 17:55 What are Arizona Cardinals' greatest needs in the draft?
- 17:34 Cardinals 7-round mock draft nets WR, CB and yes, a QB with 1st 3...
- 15:32 Arizona Coyotes rookie Clayton Keller named finalist for Calder trophy
- 15:27 Diamondbacks are planning for Jake Lamb to return on Tuesday
- 14:24 Detroit Tigers, Michael Fulmer give Make-A-Wish recipient day to...
- 13:58 White House: No plans by Trump to fire Mueller, Rosenstein